Encompass Health Corporation (EHC) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Encompass Health Corporation (EHC) carries a Roarable Rating of C+ (Hold) with 69/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How EHC Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $5.94B | 44% | 11.3% | $566.2M | $367.1M | 12.9% |
| FY 2024 | $5.37B | 44% | 10% | $455.7M | $268.6M | 11.7% |
| FY 2023 | $4.80B | 44% | 8.7% | $352.0M | $178.2M | 7.6% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring EHC)
- ✓Live walkthrough of EHC's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
EHC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +10.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on EHC today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for EHC. Explore sector supply chains on /butterfly.
EHC Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Encompass Health Corporation (EHC)?
In FY 2025 (10-K), EHC converted $5.9B of revenue into a 44% gross margin, 11.3% operating margin, and $367.1M in free cash flow (6.2% FCF margin).